£80.67

This is the most expensive it has ever been. Walk away.

£81 today · previous high £81 · all-time low £81

Springer Glioma: Immunotherapeutic Approaches: 746 (Advances in Experimental Medicine and Biology, 746)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical
Generating forecast…
£80.67 £80.66 £80.66 £80.66 £80.67 £80.67 £80.67 24 July 2026 10 August 2026 27 August 2026 13 September 2026 01 October 2026
View at Amazon ↗

Price data last checked 21 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 70 days • 1 price levels

Days at Price
70 days 0 18 35 53 70 £81 Days at Price

Price Analysis

Most common price: £81 (70 days, 100.0%)

Price range: £81 - £81

Price levels: 1 different prices over 70 days

Description

Treatment of glioma is currently one of the most challenging problems in oncology, as well as in neurosurgery. Despite major advances in our understanding of the pathomechanism, diagnosis by imaging and the availability of powerful therapeutic tools, the life expectancy of patients with glioblastoma has only been slightly prolonged and a cure remains elusive. None of the currently available surgical tools, including operative microscopes, lasers and image-guided surgery, can enable the detection and removal of all of the tumor tissue. In recent years, however, the landscape has been changing immeasurably, and molecular studies over the past two decades have identified a variety of genetic aberrations that are specifically associated with individual types of gliomas. In addition, certain molecular abnormalities have been linked to therapy responses, thereby establishing clinical biomarkers and molecular targets, and the use of novel agents is being investigated. These agents have been specifically engineered to exert specific cytotoxicity against gliomas, either on their own as single agents or in combination with other modalities. Moreover, there has been an enormous surge of interest in the area of immunology and immunotherapy, which has been facilitated by our understanding of the molecular basis of gliomas. Although several kinds of immunotherapeutic trials have been undertaken, we still await a great breakthrough in terms of clinical efficacy to prolong the survival time of glioma patients.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£155.47 27 Sep 2026
Neuro-Oncology Part II - Handbook Clinical Neurology Vol 105
97% match

Neuro-Oncology Part II - Handbook Clinical Neurology Vol 105

Elsevier

£127.99 02 Oct 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.71 02 Sep 2026
Tumors of the Pediatric Central Nervous System
97% match

Tumors of the Pediatric Central Nervous System

Thieme

£196.53 30 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.78 02 Sep 2026
Molecular Pathology of Nervous System Tumors - Springer Medical Guide
97% match

Molecular Pathology of Nervous System Tumors - Springer Medical Guide

Springer

£99.56 17 Sep 2026
MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)
97% match

MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)

£166.00 25 Sep 2026
Quality and Safety in Neurosurgery
97% match

Quality and Safety in Neurosurgery

Academic Press

£114.99 01 Oct 2026
Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
97% match

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

Academic Press

£224.02 03 Sep 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
97% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 26 Sep 2026
Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)
97% match

Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)

Springer

£120.59 17 Sep 2026
Immunotherapeutic Strategies for the Treatment of Glioma (Volume 3) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 3)
97% match

Immunotherapeutic Strategies for the Treatment of Glioma (Volume 3) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 3)

Elsevier

£123.92 24 Sep 2026
Pediatric Cancer, Volume 2: Teratoid/Rhabdoid, Brain Tumors, and Glioma
97% match

Pediatric Cancer, Volume 2: Teratoid/Rhabdoid, Brain Tumors, and Glioma

Springer

£95.07 24 Sep 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£147.49 24 Sep 2026
Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America: Volume 36-1 (The Clinics: Internal Medicine, Volume 36-1)
97% match

Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America: Volume 36-1 (The Clinics: Internal Medicine, Volume 36-1)

Elsevier

£76.99 18 Sep 2026
Robotergeführte Radiochirurgie: Extracranielle Indikationen
97% match

Robotergeführte Radiochirurgie: Extracranielle Indikationen

De Gruyter

£79.92 02 Oct 2026
Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1
97% match

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1

Elsevier

£117.95 01 Oct 2026
Evidence based practice in Neuro-oncology
97% match

Evidence based practice in Neuro-oncology

Springer

£81.74 17 Sep 2026
Atlas of Brain and Spine Oncology Imaging: 5 (Atlas of Oncology Imaging)
96% match

Atlas of Brain and Spine Oncology Imaging: 5 (Atlas of Oncology Imaging)

Springer

£95.63 02 Oct 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
96% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Elsevier

£119.00 23 Sep 2026